20th Jan 2014 13:36
LONDON (Alliance News) - Vectura Group PLC said Monday that its partner Sandoz has launched its AirFluSal Forspiro asthma inhaler in Denmark.
AirFluSal Forspiro received EU market authorisation in Denmark December 18 2013.
Sandoz is the generics division of Swiss pharmaceutical company Novartis AG.
Shares in Vectura were trading up 1% at 159.00 pence Monday afternoon.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
VEC.L